Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485
Published May 13, 2026 · Recall initiated: April 1, 2026
Summary
FDA records medical device Class II recall Z-2081-2026, published May 13, 2026 and initiated April 1, 2026. Recalling firm: BioFire Diagnostics, LLC; Status: Ongoing; Reported quantity: 2400 pouches; Lot: Lot Number: 2215125/UDI: 00815381020390. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Respiratory/sore throat panel test may result in false negative results and control failures.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- BioFire Diagnostics, LLC
- Distributor
- US Nationwide distribution in the states of MS, TX MN, VA.
- Lot
- Lot Number: 2215125/UDI: 00815381020390
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAGeneric Name: FilmArray® Pneumonia Panel Generic Name: FilmArray® Pneumonia Panel Model/Catalog Number:October 21, 2026
- FDAGeneric Name: BioFire® Joint Infection (JI) Panel Generic Name: BioFire® Joint Infection (JI) PanelOctober 21, 2026
- FDAGeneric Name: FilmArray® Pneumonia Panel plus Generic Name: FilmArray® Pneumonia Panel plus Model/CatalogOctober 21, 2026
- FDABIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acidAugust 19, 2026
- FDADEX Ophthalmic Tissue Forceps, 27ga DEX Stiff Super Grip Forceps, Model/Catalog Number: DVF4034-27May 13, 2026
- FDAOne Step 10A in vitro diagnostic testMay 13, 2026
Questions about this recall
Was Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485 recalled?
Yes. FDA published recall Z-2081-2026 on May 13, 2026. Reported hazard: Respiratory/sore throat panel test may result in false negative results and control failures.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail